Oncology dealmaking fuels biotech M&A
JD Supra: Mergers
FEBRUARY 23, 2024
Global spending on cancer medicines is set to reach US$375 billion by 2027, with innovation in drug discovery and development ramping up to meet rising demand. While the global biotech sector continues to grapple with elevated interest rates and plunging valuations, the oncology sector continues to attract dealmaker interest.
Let's personalize your content